StockData
Evotec SE logo

Evotec SE (EVO) income statement

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.32−0.13 (-8.97%)

Close on Nov 20, 2026Market cap $469.34MP/E –Yield –

See a number that looks wrong?